trending Market Intelligence /marketintelligence/en/news-insights/trending/UIocWo5UI9sbY7A44eme1A2 content esgSubNav
In This List

Henry Schein plans Nasdaq listing of animal health spin-off Covetrus, sets date

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Henry Schein plans Nasdaq listing of animal health spin-off Covetrus, sets date

Henry Schein Inc. said it plans to list the shares of its spin-off company Covetrus on the Nasdaq Global Select Market under the symbol CVET.

Covetrus was formed after the spin-off of Henry Schein's Animal Health business, which was then merged with Vets First Choice.

Melville, N.Y.-based Henry Schein said the record date for Covetrus' new shares has been set for Jan. 17, while the distribution of shares is expected to take place Feb. 4.

Henry Schein shareholders will receive 0.4 of a Covetrus common stock for every share they hold in the company.

Henry Schein common stock will continue to trade on Nasdaq under the symbol HSIC.